CEO Bret Barnhizer stated: We have entered into : Confidentiality Agreements with two diagnostic and financial groups in the last week for this purpose and are inviting additional interest."
"NanoLogix does not possess the scale of production or marketing required for this essential test distribution for COVID-19. We cannot expand rapidly enough to meet the immediate need for testing.